Table 4.

The serum expression level of FGA, APOA-1 and AHSG in different groups

	Control group (n = 28)	I/II GC-pre (n = 16)	III/IV GC-pre (n = 26)	I/II GC-post (n = 16)	III/IV GC-post (n = 26)	CRC (n = 30)	HCC (n = 30)
FGA (ng/ml)	406.80 ± 42.52 (330.14–490.51)	544.05 ± 53.74 (447.79–642.26)	814.19 ± 85.74 (676.96–950.09)	403.54 ± 46.80 (428.47–598.98)	664.13 ± 63.38 (556.04–755.03)	630.94 ± 96.46 (429.35–800.72)	596.70 ± 67.63 (450.21–779.29)
AHSG (μg/ml)	291.83 ± 47.24 (204.48–375.66)	353.74 ± 49.51 (244.96–441.11)	455.79 ± 59.74 (385.38–606.92)	324.74 ± 41.81 (244.41–401.99)	420.17 ± 53.98 (354.95–548.11)	337.34 ± 49.78 (224.17–423.79)	351.26 ± 41.66 (262.71–441.91)
AOPA-I (μg/ml)	3.44 ± 0.96 (2.03–5.44)	5.91 ± 1.19 (4.66–8.23)	3.71 ± 0.79 (2.67–6.19)	4.52 ± 1.14 (3.21–6.92)	3.31 ± 0.82 (1.97–5.02)	3.82 ± 0.65 (2.80–5.67)	2.25 ± 0.93 (0.84–4.10)